Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1823-1834

  Li, Xiao Feng ^a,c   Charnock Jones, D Stephen ^a,c   Zhang, Eko ^a,c   Hiby, Susan ^b   Malik, Shazia ^a,c   Day, Kate ^a,c   Licence, Diane ^a,c   Bowen, J Mark ^b,d   Gardner, Lucy ^b,d   King, Ashley ^b,d   Loke, Yung Wai ^b,d   Smith, Stephen K ^a,b,c  

^a Reproductive Molecular Research Group   (United Kingdom)

^b Research Group in Human Reproductive Immunobiology   (United Kingdom)

^c Rosie Maternity Hospital   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; GROWTH FACTOR; INTERLEUKIN 15; INTERLEUKIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MENORRHAGIA; MENSTRUAL CYCLE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-2; APOPTOSIS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOCHROME C GROUP; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; MENSTRUAL CYCLE; NEOPLASM PROTEINS; PREGNANCY PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-1; RECEPTOR, TIE-2; RECEPTORS, GROWTH FACTOR; RECEPTORS, TIE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; UMBILICAL VEINS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0141814852     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.4.1823     Document Type: Article

References (65)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
3. Angiogenesis of the endometrium
4. Three-dimensional aspects of villous maldevelopment
5. The pathophysiology of menorrhagia
6. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
7. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470
8. Vascular endothelial growth factors VEGF-B and VEGF-C
9. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
10. Vascular endothelial growth factor-C promotes angiogenesis in the setting of tissue ischemia
11. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
12. A novel type of vascular endothelial growth factor, VEGF-E, preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin binding domain
13. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor, are transcribed from a single gene of chromosome 14
14. The biology of vascular endothelial growth factors
15. Angiogenesis in embryos and ischaemic diseases
16. Endothelial receptor tyrosine kinases involved in angiogenesis
17. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
18. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
19. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity. in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
20. Signaling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors
21. Identification and localisation of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell line
22. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endoemtriosis
23. Vascular endothelial growth factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen induced increases in uterine capillary permeability and growth
24. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
25. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning
26. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis
27. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
28. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
29. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
30. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
31. Human uterine lymphocytes
32. Co-stimulation of human decidual natural killer cells by interleukin-2 and stromal cells
33. Human decidual natural killer (NK) cells express the receptor for IL-15 and respond to the cytokine
34. The influence of the maternal uterine immune response on placentation in human subjects
35. During angiogenesis, vascular endothelial growth facotor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium
36. Dating of the endometrial biopsy
37. Endometrium
38. Localization of VEGF and expression of its receptors Flt and KDR in human placenta throughout pregnancy
39. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor, VEGF-B and VEGF-C in the human placenta throughout gestation
40. The involvement of IL-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus
41. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia
42. Features of apoptotic cells measured by flow cytometry
43. Annexin V affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
44. Early detection of apoptosis using a fluorescent conjugate of annexin V
45. Vascular endothelial growth factor C induces angiogenesis in vivo
46. Evaluation of estrogen and progesterone receptor expression in uterine mucosal lymphocytes
47. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle
48. ++ population
49. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells
50. Granzymes D, E, F, and G are regulated through pregnancy and by IL-2 and IL-15 in granulated metrial gland cells
51. Cytokine production and cytokine receptor expression by cells of the human first trimester placental uterine interface
52. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
53. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
54. - tumor cells
55. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium
56. IL-2 activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis
57. Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells
58. NK cells and apoptosis
59. Apoptosis of human endometrium mediated by perforin and granzyme B of NK cells and cytotoxic T lymphocytes
60. Can Murine uterine natural killer cells give insights into the pathogenesis of preeclampsia?
61. Immune competence involving the natural killer cell lineage promotes placental growth
62. Engraftment of NK cells reverses the reproductive deficits in pregnant NK cell and T cell deficient Tgε26 mice
63. Interferon-γ contributes to the normalcy of murine pregnancy
64. Vascular smooth muscle cell proliferation in arterioles of the human endometrium